Please use this identifier to cite or link to this item:
https://doi.org/10.21256/zhaw-19725
Publication type: | Article in scientific journal |
Type of review: | Peer review (publication) |
Title: | Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials |
Authors: | Hengartner, Michael Pascal Jakobsen, Janus C. Sørensen, Anders Plöderl, Martin |
et. al: | No |
DOI: | 10.1371/journal.pone.0229381 10.21256/zhaw-19725 |
Published in: | PLOS ONE |
Volume(Issue): | 15 |
Issue: | 2 |
Page(s): | e0229381 |
Issue Date: | 2020 |
Publisher / Ed. Institution: | Public Library of Science |
ISSN: | 1932-6203 |
Language: | English |
Subject (DDC): | 616.8: Neurology, diseases of nervous system |
Abstract: | It has been claimed that efficacy estimates based on the Hamilton Depression Rating-Scale (HDRS) underestimate antidepressants true treatment effects due to the instrument's poor psychometric properties. The aim of this study is to compare efficacy estimates based on the HDRS with the gold standard procedure, the Montgomery-Asberg Depression Rating-Scale (MADRS). |
URI: | https://digitalcollection.zhaw.ch/handle/11475/19725 |
Fulltext version: | Published version |
License (according to publishing contract): | CC BY 4.0: Attribution 4.0 International |
Departement: | Applied Psychology |
Organisational Unit: | Psychological Institute (PI) |
Appears in collections: | Publikationen Angewandte Psychologie |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
2020_Hengartner-etal_New-generation-antidepressants.pdf | 898.34 kB | Adobe PDF | View/Open |
Show full item record
Hengartner, M. P., Jakobsen, J. C., Sørensen, A., & Plöderl, M. (2020). Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials. Plos One, 15(2), e0229381. https://doi.org/10.1371/journal.pone.0229381
Hengartner, M.P. et al. (2020) ‘Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials’, PLOS ONE, 15(2), p. e0229381. Available at: https://doi.org/10.1371/journal.pone.0229381.
M. P. Hengartner, J. C. Jakobsen, A. Sørensen, and M. Plöderl, “Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials,” PLOS ONE, vol. 15, no. 2, p. e0229381, 2020, doi: 10.1371/journal.pone.0229381.
HENGARTNER, Michael Pascal, Janus C. JAKOBSEN, Anders SØRENSEN und Martin PLÖDERL, 2020. Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials. PLOS ONE. 2020. Bd. 15, Nr. 2, S. e0229381. DOI 10.1371/journal.pone.0229381
Hengartner, Michael Pascal, Janus C. Jakobsen, Anders Sørensen, and Martin Plöderl. 2020. “Efficacy of New-Generation Antidepressants Assessed with the Montgomery-Asberg Depression Rating Scale, the Gold Standard Clinician Rating Scale : A Meta-Analysis of Randomised Placebo-Controlled Trials.” Plos One 15 (2): e0229381. https://doi.org/10.1371/journal.pone.0229381.
Hengartner, Michael Pascal, et al. “Efficacy of New-Generation Antidepressants Assessed with the Montgomery-Asberg Depression Rating Scale, the Gold Standard Clinician Rating Scale : A Meta-Analysis of Randomised Placebo-Controlled Trials.” Plos One, vol. 15, no. 2, 2020, p. e0229381, https://doi.org/10.1371/journal.pone.0229381.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.